These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22070192)

  • 1. Histamine pharmacology and new CNS drug targets.
    Tiligada E; Kyriakidis K; Chazot PL; Passani MB
    CNS Neurosci Ther; 2011 Dec; 17(6):620-8. PubMed ID: 22070192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine H3 and H4 receptors as novel drug targets.
    Tiligada E; Zampeli E; Sander K; Stark H
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histaminergic control of sleep-wake cycles: recent therapeutic advances for sleep and wake disorders.
    Barbier AJ; Bradbury MJ
    CNS Neurol Disord Drug Targets; 2007 Feb; 6(1):31-43. PubMed ID: 17305552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine in cancer: the dual faces of the coin.
    Cianchi F; Vinci MC; Masini E
    Cancer Biol Ther; 2008 Jan; 7(1):36-7. PubMed ID: 18347416
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment.
    Medina V; Croci M; Crescenti E; Mohamad N; Sanchez-Jiménez F; Massari N; Nuñez M; Cricco G; Martin G; Bergoc R; Rivera E
    Cancer Biol Ther; 2008 Jan; 7(1):28-35. PubMed ID: 17932461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
    Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
    Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of histaminergic compounds in the treatment of addiction and drug-related cognitive disorders.
    Alleva L; Tirelli E; Brabant C
    Behav Brain Res; 2013 Jan; 237():357-68. PubMed ID: 23000530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders.
    Esbenshade TA; Browman KE; Bitner RS; Strakhova M; Cowart MD; Brioni JD
    Br J Pharmacol; 2008 Jul; 154(6):1166-81. PubMed ID: 18469850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the histamine H4 receptor have a pro- or anti-inflammatory role in murine bronchial asthma?
    Neumann D; Beermann S; Seifert R
    Pharmacology; 2010; 85(4):217-23. PubMed ID: 20215812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine H3 receptor antagonists go to clinics.
    Sander K; Kottke T; Stark H
    Biol Pharm Bull; 2008 Dec; 31(12):2163-81. PubMed ID: 19043195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in histamine pharmacology reveal new drug targets.
    Chazot PL
    Br J Pharmacol; 2009 May; 157(1):1-3. PubMed ID: 19413566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
    Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
    Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases.
    Sadek B; Saad A; Sadeq A; Jalal F; Stark H
    Behav Brain Res; 2016 Oct; 312():415-30. PubMed ID: 27363923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug targets for cognitive enhancement in neuropsychiatric disorders.
    Wallace TL; Ballard TM; Pouzet B; Riedel WJ; Wettstein JG
    Pharmacol Biochem Behav; 2011 Aug; 99(2):130-45. PubMed ID: 21463652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of histamine H3 and H4 receptors in mechanical hyperalgesia following peripheral nerve injury.
    Smith FM; Haskelberg H; Tracey DJ; Moalem-Taylor G
    Neuroimmunomodulation; 2007; 14(6):317-25. PubMed ID: 18401194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H3 receptors and sleep-wake regulation.
    Lin JS; Sergeeva OA; Haas HL
    J Pharmacol Exp Ther; 2011 Jan; 336(1):17-23. PubMed ID: 20864502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine H(4) receptors regulate ACTH release in AtT-20 cells.
    Meng J; Ma X; Li M; Jia M; Luo X
    Eur J Pharmacol; 2008 Jun; 587(1-3):336-8. PubMed ID: 18439995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neglected role of histamine in Alzheimer's disease.
    Naddafi F; Mirshafiey A
    Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):327-36. PubMed ID: 23677734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system.
    Witkin JM; Nelson DL
    Pharmacol Ther; 2004 Jul; 103(1):1-20. PubMed ID: 15251226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Neuropharmacology; 2010 Sep; 59(3):180-9. PubMed ID: 20493888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.